Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Readmission | 7 | 2024 | 162 | 2.290 |
Why?
|
Patient Discharge | 7 | 2022 | 153 | 2.210 |
Why?
|
Retrospective Studies | 15 | 2023 | 2550 | 1.250 |
Why?
|
Transitional Care | 2 | 2024 | 20 | 1.110 |
Why?
|
Hospitals | 3 | 2022 | 80 | 0.930 |
Why?
|
Practice Patterns, Physicians' | 4 | 2022 | 350 | 0.890 |
Why?
|
Delivery of Health Care, Integrated | 5 | 2022 | 567 | 0.890 |
Why?
|
Telemedicine | 2 | 2024 | 184 | 0.830 |
Why?
|
Dexamethasone | 1 | 2022 | 11 | 0.820 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 25 | 0.810 |
Why?
|
Humans | 36 | 2024 | 18430 | 0.780 |
Why?
|
Medical Audit | 2 | 2020 | 41 | 0.730 |
Why?
|
Emergency Service, Hospital | 8 | 2023 | 382 | 0.730 |
Why?
|
Outpatients | 2 | 2020 | 111 | 0.720 |
Why?
|
Medical Records | 2 | 2020 | 106 | 0.710 |
Why?
|
Self Report | 2 | 2022 | 256 | 0.670 |
Why?
|
Disease Progression | 1 | 2020 | 271 | 0.660 |
Why?
|
Aged | 19 | 2024 | 6417 | 0.650 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 199 | 0.610 |
Why?
|
Male | 23 | 2023 | 10440 | 0.590 |
Why?
|
Skilled Nursing Facilities | 1 | 2017 | 8 | 0.590 |
Why?
|
Female | 27 | 2024 | 13136 | 0.590 |
Why?
|
Research Design | 1 | 2020 | 402 | 0.580 |
Why?
|
Papillomavirus Infections | 3 | 2024 | 136 | 0.580 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 55 | 0.570 |
Why?
|
Acute Coronary Syndrome | 3 | 2021 | 17 | 0.550 |
Why?
|
Patient Selection | 1 | 2017 | 198 | 0.540 |
Why?
|
Aged, 80 and over | 9 | 2020 | 2003 | 0.530 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 142 | 0.530 |
Why?
|
Adult | 15 | 2024 | 7910 | 0.530 |
Why?
|
Medicare | 1 | 2017 | 214 | 0.510 |
Why?
|
Myocardial Infarction | 3 | 2023 | 249 | 0.510 |
Why?
|
Middle Aged | 19 | 2024 | 8284 | 0.510 |
Why?
|
Exercise | 1 | 2020 | 495 | 0.510 |
Why?
|
Lung Neoplasms | 1 | 2017 | 259 | 0.460 |
Why?
|
Sinusitis | 3 | 2017 | 14 | 0.430 |
Why?
|
Electronic Health Records | 7 | 2020 | 747 | 0.420 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2024 | 127 | 0.400 |
Why?
|
Pandemics | 3 | 2024 | 292 | 0.400 |
Why?
|
California | 11 | 2024 | 2365 | 0.380 |
Why?
|
Bariatric Surgery | 2 | 2023 | 130 | 0.360 |
Why?
|
Mass Screening | 4 | 2024 | 690 | 0.360 |
Why?
|
Risk Assessment | 5 | 2023 | 1143 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 208 | 0.320 |
Why?
|
Guideline Adherence | 4 | 2017 | 162 | 0.310 |
Why?
|
Follow-Up Studies | 3 | 2021 | 1269 | 0.290 |
Why?
|
Craniocerebral Trauma | 2 | 2017 | 10 | 0.290 |
Why?
|
Troponin | 2 | 2023 | 9 | 0.280 |
Why?
|
Tissue Plasminogen Activator | 2 | 2016 | 23 | 0.270 |
Why?
|
Breast Neoplasms | 3 | 2022 | 1037 | 0.260 |
Why?
|
Early Detection of Cancer | 4 | 2024 | 526 | 0.250 |
Why?
|
Chest Pain | 2 | 2023 | 14 | 0.240 |
Why?
|
Stroke | 2 | 2016 | 311 | 0.220 |
Why?
|
Sampling Studies | 2 | 2020 | 55 | 0.210 |
Why?
|
Aftercare | 1 | 2022 | 48 | 0.200 |
Why?
|
Neoplasm Staging | 3 | 2017 | 337 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 392 | 0.200 |
Why?
|
Practice Guidelines as Topic | 4 | 2017 | 333 | 0.190 |
Why?
|
Cohort Studies | 3 | 2023 | 2672 | 0.190 |
Why?
|
Community Health Services | 1 | 2022 | 86 | 0.190 |
Why?
|
United States | 4 | 2017 | 4164 | 0.190 |
Why?
|
Troponin I | 1 | 2021 | 8 | 0.190 |
Why?
|
Critical Pathways | 1 | 2021 | 11 | 0.190 |
Why?
|
Dementia | 1 | 2023 | 105 | 0.190 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 118 | 0.190 |
Why?
|
Clinical Decision-Making | 1 | 2021 | 36 | 0.190 |
Why?
|
Obesity, Morbid | 1 | 2022 | 120 | 0.180 |
Why?
|
Patient Portals | 1 | 2021 | 25 | 0.180 |
Why?
|
Heart Diseases | 1 | 2021 | 77 | 0.180 |
Why?
|
Telephone | 1 | 2021 | 179 | 0.180 |
Why?
|
Referral and Consultation | 1 | 2022 | 180 | 0.180 |
Why?
|
Exercise Test | 1 | 2020 | 45 | 0.170 |
Why?
|
Surveys and Questionnaires | 3 | 2024 | 1389 | 0.170 |
Why?
|
Hospitals, Community | 2 | 2017 | 23 | 0.170 |
Why?
|
Hospice and Palliative Care Nursing | 1 | 2019 | 6 | 0.170 |
Why?
|
House Calls | 1 | 2019 | 13 | 0.170 |
Why?
|
Home Care Services | 1 | 2019 | 23 | 0.170 |
Why?
|
Regression Analysis | 1 | 2020 | 319 | 0.170 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 270 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 197 | 0.160 |
Why?
|
Algorithms | 1 | 2020 | 241 | 0.160 |
Why?
|
Registries | 2 | 2017 | 490 | 0.150 |
Why?
|
Education, Continuing | 1 | 2017 | 3 | 0.150 |
Why?
|
Antimicrobial Stewardship | 1 | 2017 | 6 | 0.150 |
Why?
|
Heart Failure | 1 | 2023 | 398 | 0.150 |
Why?
|
Income | 1 | 2017 | 98 | 0.150 |
Why?
|
Health Care Costs | 1 | 2019 | 251 | 0.140 |
Why?
|
Survival Analysis | 1 | 2017 | 226 | 0.140 |
Why?
|
Delivery of Health Care | 2 | 2022 | 444 | 0.140 |
Why?
|
Depression | 1 | 2022 | 518 | 0.140 |
Why?
|
Patient Satisfaction | 1 | 2017 | 232 | 0.140 |
Why?
|
Odds Ratio | 4 | 2021 | 701 | 0.140 |
Why?
|
Prospective Studies | 4 | 2023 | 1314 | 0.130 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 44 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 26 | 0.130 |
Why?
|
Prognosis | 1 | 2017 | 624 | 0.130 |
Why?
|
Comorbidity | 1 | 2017 | 619 | 0.130 |
Why?
|
Critical Care | 1 | 2016 | 73 | 0.130 |
Why?
|
Accelerometry | 1 | 2015 | 37 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 46 | 0.120 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 146 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 34 | 0.120 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 656 | 0.120 |
Why?
|
Walking | 1 | 2015 | 87 | 0.120 |
Why?
|
Maternal Exposure | 1 | 2014 | 60 | 0.120 |
Why?
|
Air Pollutants | 1 | 2014 | 52 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2016 | 166 | 0.120 |
Why?
|
Air Pollution | 1 | 2014 | 42 | 0.120 |
Why?
|
Population Surveillance | 1 | 2015 | 271 | 0.120 |
Why?
|
Internet | 1 | 2016 | 243 | 0.110 |
Why?
|
Ambulatory Care | 1 | 2015 | 266 | 0.110 |
Why?
|
Health Maintenance Organizations | 1 | 2015 | 479 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2023 | 724 | 0.110 |
Why?
|
Chronic Disease | 1 | 2016 | 468 | 0.110 |
Why?
|
Primary Health Care | 2 | 2017 | 848 | 0.100 |
Why?
|
Logistic Models | 3 | 2020 | 962 | 0.100 |
Why?
|
Body Mass Index | 1 | 2014 | 974 | 0.090 |
Why?
|
Weight Loss | 2 | 2023 | 321 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 407 | 0.080 |
Why?
|
Canada | 2 | 2017 | 67 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 2 | 2017 | 56 | 0.070 |
Why?
|
Acute Disease | 2 | 2017 | 144 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 28 | 0.060 |
Why?
|
Papanicolaou Test | 1 | 2024 | 38 | 0.060 |
Why?
|
Vaginal Smears | 1 | 2024 | 50 | 0.060 |
Why?
|
Papillomaviridae | 1 | 2024 | 53 | 0.060 |
Why?
|
Perception | 1 | 2024 | 59 | 0.060 |
Why?
|
Mammography | 2 | 2015 | 174 | 0.060 |
Why?
|
Sleep | 1 | 2022 | 57 | 0.050 |
Why?
|
Pragmatic Clinical Trials as Topic | 1 | 2022 | 56 | 0.050 |
Why?
|
Child | 2 | 2022 | 2571 | 0.050 |
Why?
|
Social Class | 1 | 2022 | 125 | 0.050 |
Why?
|
Medical Oncology | 1 | 2022 | 32 | 0.050 |
Why?
|
Angina, Unstable | 1 | 2021 | 7 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2021 | 22 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 342 | 0.050 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2021 | 22 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 26 | 0.050 |
Why?
|
Government Programs | 1 | 2020 | 11 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2023 | 256 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 673 | 0.040 |
Why?
|
Health Priorities | 1 | 2020 | 28 | 0.040 |
Why?
|
Research Personnel | 1 | 2020 | 30 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2022 | 214 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 61 | 0.040 |
Why?
|
Occult Blood | 1 | 2021 | 167 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 321 | 0.040 |
Why?
|
Natural Language Processing | 1 | 2020 | 57 | 0.040 |
Why?
|
Oregon | 1 | 2019 | 222 | 0.040 |
Why?
|
Biomarkers | 1 | 2020 | 308 | 0.040 |
Why?
|
Infant | 1 | 2023 | 1245 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2022 | 1296 | 0.040 |
Why?
|
Sex Factors | 1 | 2021 | 661 | 0.040 |
Why?
|
Washington | 1 | 2019 | 388 | 0.040 |
Why?
|
Child, Preschool | 1 | 2023 | 1478 | 0.040 |
Why?
|
Young Adult | 2 | 2015 | 2518 | 0.040 |
Why?
|
Vaccination | 1 | 2022 | 674 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 48 | 0.040 |
Why?
|
Interrupted Time Series Analysis | 1 | 2017 | 24 | 0.040 |
Why?
|
Hospitalization | 1 | 2023 | 847 | 0.040 |
Why?
|
Hemorrhage | 1 | 2016 | 63 | 0.030 |
Why?
|
Adolescent | 2 | 2015 | 3798 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2015 | 9 | 0.030 |
Why?
|
Mid-Atlantic Region | 1 | 2015 | 9 | 0.030 |
Why?
|
Northwestern United States | 1 | 2015 | 58 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2017 | 399 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2015 | 49 | 0.030 |
Why?
|
Risk Factors | 1 | 2023 | 3449 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 41 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2014 | 23 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2016 | 136 | 0.030 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2016 | 254 | 0.030 |
Why?
|
Age Distribution | 1 | 2015 | 261 | 0.030 |
Why?
|
Survivors | 1 | 2015 | 158 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 365 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2014 | 115 | 0.030 |
Why?
|
Health Promotion | 1 | 2016 | 294 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2015 | 211 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 1136 | 0.020 |
Why?
|
Smoking | 1 | 2014 | 494 | 0.020 |
Why?
|
Pregnancy | 1 | 2014 | 1516 | 0.020 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->